Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The state is accusing the insurer of colluding with the broader Blue Cross Blue Shield network to stifle competition and control prices. BCBSM denies the allegations.
The hack, which was revealed earlier this year in a report from Bleeping Computer, is said to have been limited to a legacy server. Oracle denied its cloud environment had been compromised.
Independence Blue Cross, the largest medical insurance provider in the Philadelphia area, does not admit to wrongdoing. It was accused in a lawsuit backed by the U.S. Department of Justice of misrepresenting the severity of patient illnesses to juice risk-adjusted Medicare payments.
With its $350M in new funding, EliseAI said it plans to build out its technology and sales force. It currently works with specialty provider groups to automate practice operations such as scheduling and insurance verification.
Physician-founded Counsel Health said it will use the funds to hire more doctors as it expands the userbase for its AI, which allows patients to ask questions and get answers from a real doctor.
The division develops and manufactures knee and hip replacements, along with other surgical implants. J&J said it will separate DePuy within 18 to 24 months, at which point it will be the largest orthopedics company in the world.
According to the Wall Street Journal, insider sources said a major update to Microsoft’s AI chatbot could be released before the end of the month, designed to be more reliable at answering medical queries.
The Accountability Board has submitted an official proposal for UnitedHealth Group to separate its CEO and board chair positions, both currently held by Stephen Hemsley.
Qualtrics, which uses artificial intelligence to measure public satisfaction and consumer trends, is buying Press Ganey outright, citing the need for more healthcare-specific data to improve its technology.
The new contract was signed just ahead of the Oct. 20 deadline. The insurer and academic health system were in dispute over reimbursement rates. The exact terms of the new multi-year agreement are unknown.
The new "TrumpRx.com" will sell Pfizer drugs at a heavily discounted price, direct-to-consumers. However, details on the initiative are not entirely clear.